Results 1 to 2 of 2
Page 1 of 1
TypeTitleAuthor(s)YearViews
Responses to peginterferon alfa-2a (40KD) (PEGASYS) treatment are durable in Asian Patients with HBeAg-Negative CHB: 12 month Follow-Up Data from a large Randomised Study
Proceedings/Conference:
Journal of Gastroenterology and Hepatology
Publisher:
Wiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/JGH
Marcellin, P; Lau, GKK; Piratvisuth, T; Jin, R; Lu, ZM; Lai, MY; Thongsawat, S; Ramakrishnan, B; Popescu, M200615
 
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B
Publisher:
Massachusetts Medical Society. The Journal's web site is located at http://content.nejm.org/
Marcellin, P; Lau, GK; Bonino, F; Farci, P; Hadziyannis, S; Jin, R; Lu, ZM; Piratvisuth, T; Germanidis, G; Yurdaydin, C; Diago, M; Gurel, S; Lai, MY; Button, P; Pluck, N2004328
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download